 | • レポートコード：D0GIR-00361 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ニューカッスル病治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。ニューカッスル病治療薬の種類別市場規模（弱毒生ワクチン、不活化ワクチン、共役ワクチン）、用途別市場規模（獣医病院、獣医クリニック、獣医研究所、小売薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Indovax、Merck、Zoetis、Eli Lilly、Ceva ・地域別グローバル市場分析 2015年-2020年 ・ニューカッスル病治療薬の北米市場（アメリカ、カナダ、メキシコ） ・ニューカッスル病治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ニューカッスル病治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ニューカッスル病治療薬の南米市場（ブラジル、アルゼンチン） ・ニューカッスル病治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：弱毒生ワクチン、不活化ワクチン、共役ワクチン ・用途別分析：獣医病院、獣医クリニック、獣医研究所、小売薬局、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Newcastle Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Newcastle Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Newcastle Disease Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Newcastle Disease Treatment market has been segmented into:
Live Attenuated Vaccine
Inactivated Vaccine
Conjugated Vaccine
By Application, Newcastle Disease Treatment has been segmented into:
Veterinary Hospitals
Veterinary Clinics
Veterinary Research Institutes
Retail Pharmacies
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Newcastle Disease Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Newcastle Disease Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Newcastle Disease Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Newcastle Disease Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Newcastle Disease Treatment Market Share Analysis
Newcastle Disease Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Newcastle Disease Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Newcastle Disease Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Newcastle Disease Treatment are:
Indovax
Merck
Zoetis
Eli Lilly
Ceva
Table of Contents
1 Newcastle Disease Treatment Market Overview
1.1 Product Overview and Scope of Newcastle Disease Treatment
1.2 Classification of Newcastle Disease Treatment by Type
1.2.1 Global Newcastle Disease Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Newcastle Disease Treatment Revenue Market Share by Type in 2019
1.2.3 Live Attenuated Vaccine
1.2.4 Inactivated Vaccine
1.2.5 Conjugated Vaccine
1.3 Global Newcastle Disease Treatment Market by Application
1.3.1 Overview: Global Newcastle Disease Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Veterinary Research Institutes
1.3.5 Retail Pharmacies
1.3.6 Others
1.4 Global Newcastle Disease Treatment Market by Regions
1.4.1 Global Newcastle Disease Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Newcastle Disease Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Newcastle Disease Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Newcastle Disease Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Newcastle Disease Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Newcastle Disease Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Newcastle Disease Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Indovax
2.1.1 Indovax Details
2.1.2 Indovax Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Indovax SWOT Analysis
2.1.4 Indovax Product and Services
2.1.5 Indovax Newcastle Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck SWOT Analysis
2.2.4 Merck Product and Services
2.2.5 Merck Newcastle Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Zoetis
2.3.1 Zoetis Details
2.3.2 Zoetis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Zoetis SWOT Analysis
2.3.4 Zoetis Product and Services
2.3.5 Zoetis Newcastle Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Eli Lilly SWOT Analysis
2.4.4 Eli Lilly Product and Services
2.4.5 Eli Lilly Newcastle Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ceva
2.5.1 Ceva Details
2.5.2 Ceva Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Ceva SWOT Analysis
2.5.4 Ceva Product and Services
2.5.5 Ceva Newcastle Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Newcastle Disease Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Newcastle Disease Treatment Players Market Share
3.2.2 Top 10 Newcastle Disease Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Newcastle Disease Treatment Revenue and Market Share by Regions
4.2 North America Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
5 North America Newcastle Disease Treatment Revenue by Countries
5.1 North America Newcastle Disease Treatment Revenue by Countries (2015-2020)
5.2 USA Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
6 Europe Newcastle Disease Treatment Revenue by Countries
6.1 Europe Newcastle Disease Treatment Revenue by Countries (2015-2020)
6.2 Germany Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
6.4 France Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Newcastle Disease Treatment Revenue by Countries
7.1 Asia-Pacific Newcastle Disease Treatment Revenue by Countries (2015-2020)
7.2 China Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
7.5 India Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
8 South America Newcastle Disease Treatment Revenue by Countries
8.1 South America Newcastle Disease Treatment Revenue by Countries (2015-2020)
8.2 Brazil Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Newcastle Disease Treatment by Countries
9.1 Middle East & Africa Newcastle Disease Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Newcastle Disease Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Newcastle Disease Treatment Market Forecast by Type (2019-2024)
10.3 Live Attenuated Vaccine Revenue Growth Rate (2015-2025)
10.4 Inactivated Vaccine Revenue Growth Rate (2015-2025)
10.5 Conjugated Vaccine Revenue Growth Rate (2015-2025)
11 Global Newcastle Disease Treatment Market Segment by Application
11.1 Global Newcastle Disease Treatment Revenue Market Share by Application (2015-2020)
11.2 Newcastle Disease Treatment Market Forecast by Application (2019-2024)
11.3 Veterinary Hospitals Revenue Growth (2015-2020)
11.4 Veterinary Clinics Revenue Growth (2015-2020)
11.5 Veterinary Research Institutes Revenue Growth (2015-2020)
11.6 Retail Pharmacies Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Newcastle Disease Treatment Market Size Forecast (2021-2025)
12.1 Global Newcastle Disease Treatment Market Size Forecast (2021-2025)
12.2 Global Newcastle Disease Treatment Market Forecast by Regions (2021-2025)
12.3 North America Newcastle Disease Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Newcastle Disease Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Newcastle Disease Treatment Revenue Market Forecast (2021-2025)
12.6 South America Newcastle Disease Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Newcastle Disease Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Newcastle Disease Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Newcastle Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Newcastle Disease Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Newcastle Disease Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Indovax Corporate Information, Location and Competitors
Table 6. Indovax Newcastle Disease Treatment Major Business
Table 7. Indovax Newcastle Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Indovax SWOT Analysis
Table 9. Indovax Newcastle Disease Treatment Product and Solutions
Table 10. Indovax Newcastle Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Merck Corporate Information, Location and Competitors
Table 12. Merck Newcastle Disease Treatment Major Business
Table 13. Merck Newcastle Disease Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Merck SWOT Analysis
Table 15. Merck Newcastle Disease Treatment Product and Solutions
Table 16. Merck Newcastle Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Zoetis Corporate Information, Location and Competitors
Table 18. Zoetis Newcastle Disease Treatment Major Business
Table 19. Zoetis Newcastle Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Zoetis SWOT Analysis
Table 21. Zoetis Newcastle Disease Treatment Product and Solutions
Table 22. Zoetis Newcastle Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Eli Lilly Corporate Information, Location and Competitors
Table 24. Eli Lilly Newcastle Disease Treatment Major Business
Table 25. Eli Lilly Newcastle Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Eli Lilly SWOT Analysis
Table 27. Eli Lilly Newcastle Disease Treatment Product and Solutions
Table 28. Eli Lilly Newcastle Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Ceva Corporate Information, Location and Competitors
Table 30. Ceva Newcastle Disease Treatment Major Business
Table 31. Ceva Newcastle Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Ceva SWOT Analysis
Table 33. Ceva Newcastle Disease Treatment Product and Solutions
Table 34. Ceva Newcastle Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Global Newcastle Disease Treatment Revenue (Million USD) by Players (2015-2020)
Table 36. Global Newcastle Disease Treatment Revenue Share by Players (2015-2020)
Table 37. Global Newcastle Disease Treatment Revenue (Million USD) by Regions (2015-2020)
Table 38. Global Newcastle Disease Treatment Revenue Market Share by Regions (2015-2020)
Table 39. North America Newcastle Disease Treatment Revenue by Countries (2015-2020)
Table 40. North America Newcastle Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 41. Europe Newcastle Disease Treatment Revenue (Million USD) by Countries (2015-2020)
Table 42. Asia-Pacific Newcastle Disease Treatment Revenue (Million USD) by Countries (2015-2020)
Table 43. South America Newcastle Disease Treatment Revenue by Countries (2015-2020)
Table 44. South America Newcastle Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 45. Middle East and Africa Newcastle Disease Treatment Revenue (Million USD) by Countries (2015-2020)
Table 46. Middle East and Africa Newcastle Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 47. Global Newcastle Disease Treatment Revenue (Million USD) by Type (2015-2020)
Table 48. Global Newcastle Disease Treatment Revenue Share by Type (2015-2020)
Table 49. Global Newcastle Disease Treatment Revenue Forecast by Type (2021-2025)
Table 50. Global Newcastle Disease Treatment Revenue by Application (2015-2020)
Table 51. Global Newcastle Disease Treatment Revenue Share by Application (2015-2020)
Table 52. Global Newcastle Disease Treatment Revenue Forecast by Application (2021-2025)
Table 53. Global Newcastle Disease Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Newcastle Disease Treatment Picture
Figure 2. Global Newcastle Disease Treatment Revenue Market Share by Type in 2019
Figure 3. Live Attenuated Vaccine Picture
Figure 4. Inactivated Vaccine Picture
Figure 5. Conjugated Vaccine Picture
Figure 6. Newcastle Disease Treatment Revenue Market Share by Application in 2019
Figure 7. Veterinary Hospitals Picture
Figure 8. Veterinary Clinics Picture
Figure 9. Veterinary Research Institutes Picture
Figure 10. Retail Pharmacies Picture
Figure 11. Others Picture
Figure 12. Global Newcastle Disease Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Newcastle Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Newcastle Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Newcastle Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Newcastle Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Newcastle Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Newcastle Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Newcastle Disease Treatment Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Newcastle Disease Treatment Revenue Market Share in 2019
Figure 21. Global Top 10 Players Newcastle Disease Treatment Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Newcastle Disease Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Newcastle Disease Treatment Revenue Market Share by Regions (2015-2020)
Figure 25. Global Newcastle Disease Treatment Revenue Market Share by Regions in 2018
Figure 26. North America Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Europe Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 29. South America Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 31. North America Newcastle Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 32. North America Newcastle Disease Treatment Revenue Market Share by Countries in 2019
Figure 33. USA Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Canada Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Europe Newcastle Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Newcastle Disease Treatment Revenue Market Share by Countries in 2019
Figure 38. Germany Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 39. UK Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 40. France Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Russia Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Italy Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Newcastle Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Newcastle Disease Treatment Revenue Market Share by Countries in 2019
Figure 45. China Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Japan Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Korea Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 48. India Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 50. South America Newcastle Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 51. South America Newcastle Disease Treatment Revenue Market Share by Countries in 2019
Figure 52. Brazil Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Newcastle Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Newcastle Disease Treatment Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 57. UAE Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Newcastle Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 60. Global Newcastle Disease Treatment Revenue Share by Type (2015-2020)
Figure 61. Global Newcastle Disease Treatment Revenue Share by Type in 2019
Figure 62. Global Newcastle Disease Treatment Market Share Forecast by Type (2021-2025)
Figure 63. Global Live Attenuated Vaccine Revenue Growth Rate (2015-2020)
Figure 64. Global Inactivated Vaccine Revenue Growth Rate (2015-2020)
Figure 65. Global Conjugated Vaccine Revenue Growth Rate (2015-2020)
Figure 66. Global Newcastle Disease Treatment Revenue Share by Application (2015-2020)
Figure 67. Global Newcastle Disease Treatment Revenue Share by Application in 2019
Figure 68. Global Newcastle Disease Treatment Market Share Forecast by Application (2021-2025)
Figure 69. Global Veterinary Hospitals Revenue Growth Rate (2015-2020)
Figure 70. Global Veterinary Clinics Revenue Growth Rate (2015-2020)
Figure 71. Global Veterinary Research Institutes Revenue Growth Rate (2015-2020)
Figure 72. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Newcastle Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Newcastle Disease Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Newcastle Disease Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Newcastle Disease Treatment Revenue Market Forecast (2021-2025)
Figure 78. Europe Newcastle Disease Treatment Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Newcastle Disease Treatment Revenue Market Forecast (2021-2025)
Figure 80. South America Newcastle Disease Treatment Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Newcastle Disease Treatment Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
感染症治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Infectious Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.1% in the forecast period of 2020 to 2025 and will expected to reach USD 59530 million by 2025, from USD 48760 million in 2019. The Infectiou…- ブタ呼吸器疾患治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Swine Respiratory Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- ICAD（頭蓋内アテローム性動脈硬化症）病理治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global…
- メニエール病治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Meniere's Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Meniere's Disease…
- 炎症性腸疾患（IBD）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Inflammatory Bowel Disease (IBD) Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.2% in the forecast period of 2020 to 2025 and will expected to reach USD 14950 million by 2025, from USD 13690 million in 2019.…